Literature DB >> 15546074

An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis.

Yupin Suputtamongkol1, Kanigar Niwattayakul, Chuanpit Suttinont, Kitti Losuwanaluk, Roongroeng Limpaiboon, Wirongrong Chierakul, Vanaporn Wuthiekanun, Surapee Triengrim, Mongkol Chenchittikul, Nicholas J White.   

Abstract

BACKGROUND: Leptospirosis is an important cause of fever in the rural tropics. Since 1996, there has been a marked increase in the incidence of leptospirosis in northeastern Thailand. Although leptospirosis generally is susceptible to antibiotics, there is no consensus regarding the optimal treatment for severe leptospirosis.
METHODS: An open-label, randomized comparison of parenteral cefotaxime, penicillin G sodium (hereafter known as "penicillin G"), and doxycycline for the treatment of suspected severe leptospirosis was conducted. The study involved 540 patients admitted to 4 hospitals in northeastern Thailand.
RESULTS: A total of 264 patients (48.9%) had leptospirosis confirmed by serologic testing or culture. The overall mortality rate was 5%. There were no significant differences between the antibiotics with regard to associated mortality, defervescence, or time to resolution of abnormal findings of laboratory tests either among all study participants or among the subgroup of patients with confirmed leptospirosis. A total of 132 patients had rickettsial infection diagnosed, and, for these patients, treatment with doxycycline was superior to treatment with penicillin G.
CONCLUSIONS: Doxycycline or cefotaxime is a satisfactory alternative to penicillin G for the treatment of severe leptospirosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546074     DOI: 10.1086/425001

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  46 in total

1.  In vitro and in vivo activity of first generation cephalosporins against Leptospira.

Authors:  Brande M Harris; Peter J Blatz; Mary K Hinkle; Suzanne McCall; Miriam L Beckius; Katrin Mende; Janelle L Robertson; Matthew E Griffith; Clinton K Murray; Duane R Hospenthal
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

2.  A new loop-mediated isothermal amplification method for rapid, simple, and sensitive detection of Leptospira spp. in urine.

Authors:  Nobuo Koizumi; Chie Nakajima; Tsunehito Harunari; Tsutomu Tanikawa; Toshihiro Tokiwa; Eriko Uchimura; Tokujiro Furuya; Claro Niegos Mingala; Marvin Ardeza Villanueva; Makoto Ohnishi; Yasuhiko Suzuki
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

3.  Development of new, broadly reactive, rapid IgG and IgM lateral flow assays for diagnosis of scrub typhus.

Authors:  Saowaluk Silpasakorn; Nujorn Srisamut; Pattama Ekpo; Zhiwen Zhang; Chien-Chung Chao; Wei-Mei Ching; Yupin Suputtamongkol
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

4.  In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.

Authors:  Antara Chakraborty; Satoshi Miyahara; Sharon Y A M Villanueva; Nina G Gloriani; Shin-Ichi Yoshida
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

5.  Efficacy of macrolides and telithromycin against leptospirosis in a hamster model.

Authors:  James E Moon; Michael W Ellis; Michael C Ellis; Matthew E Griffith; Joshua S Hawley; Robert G Rivard; Suzanne McCall; Duane R Hospenthal; Clinton K Murray
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 6.  The kidney in leptospirosis.

Authors:  Regina C R M Abdulkader; Marcos Vinicius Silva
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

7.  Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.

Authors:  Roseanne A Ressner; Matthew E Griffith; Miriam L Beckius; Guillermo Pimentel; R Scott Miller; Katrin Mende; Susan L Fraser; Renee L Galloway; Duane R Hospenthal; Clinton K Murray
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

8.  Travel-related leptospirosis in Israel: a nationwide study.

Authors:  Eyal Leshem; Gadi Segal; Ada Barnea; Shmuel Yitzhaki; Iris Ostfeld; Silvio Pitlik; Eli Schwartz
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

9.  Bat-associated leptospirosis.

Authors:  Neelam A Vashi; Pavani Reddy; Diane B Wayne; Bradley Sabin
Journal:  J Gen Intern Med       Date:  2009-12-09       Impact factor: 5.128

10.  The infective causes of hepatitis and jaundice amongst hospitalised patients in Vientiane, Laos.

Authors:  Bounkong Syhavong; Bouachanh Rasachack; Lee Smythe; Jean-Marc Rolain; Anne-Marie Roque-Afonso; Kemajittra Jenjaroen; Vimone Soukkhaserm; Simmaly Phongmany; Rattanaphone Phetsouvanh; Sune Soukkhaserm; Te Thammavong; Mayfong Mayxay; Stuart D Blacksell; Eleanor Barnes; Philippe Parola; Elisabeth Dussaix; Didier Raoult; Isla Humphreys; Paul Klenerman; Nicholas J White; Paul N Newton
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-04-07       Impact factor: 2.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.